Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
758 9 |
Ultima descărcare din IBN: 2023-06-06 20:30 |
Căutarea după subiecte similare conform CZU |
616.65-007.61+612.57-08 (1) |
Patologia sistemului urogenital. Boli urinare şi sexuale (genitale) (392) |
Fiziologie. Fiziologie umană și comparată (725) |
SM ISO690:2012 PLEŞACOV, Alexei, VLADANOV, Ion, SCUTELNIC, Ghenadie, COLȚA, Artur, GHICAVÎI, Vitalie. Vaporezecția transuretrală Thulium laser în tratamentul hiperplaziei benigne de prostată. In: Arta Medica , 2019, nr. 1(70), pp. 62-63. ISSN 1810-1852. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Arta Medica | ||||||
Numărul 1(70) / 2019 / ISSN 1810-1852 /ISSNe 1810-1879 | ||||||
|
||||||
CZU: 616.65-007.61+612.57-08 | ||||||
Pag. 62-63 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Hiperplazia benignă de prostată reprezintă cauza cea mai frecventă a simptomelor tractului urinar inferior. Actualmente tratamentul chirurgical rămâne cea mai eicientă opțiune de tratament a acestor pacienți. Conform studiilor, utilizarea chirurgiei transuretrale Thulium laser reduce considerabil riscurile de hemoragie și practic exclude posibilitatea apariției sindromului TUR. Luând în considerare eiciența similară cu metodele endourologice clasice și siguranța sporită a tehnicii, vaporezecția transuretrală Thulium laser este recomandabilă utilizării pe larg |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-85615</cfResPublId> <cfResPublDate>2019-04-01</cfResPublDate> <cfVol>70</cfVol> <cfIssue>1</cfIssue> <cfStartPage>62</cfStartPage> <cfISSN>1810-1852</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/85615</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Vaporezecția transuretrală Thulium laser în tratamentul hiperplaziei benigne de prostată</cfTitle> <cfAbstr cfLangCode='RO' cfTrans='o'><p>Hiperplazia benignă de prostată reprezintă cauza cea mai frecventă a simptomelor tractului urinar inferior. Actualmente tratamentul chirurgical rămâne cea mai eicientă opțiune de tratament a acestor pacienți. Conform studiilor, utilizarea chirurgiei transuretrale Thulium laser reduce considerabil riscurile de hemoragie și practic exclude posibilitatea apariției sindromului TUR. Luând în considerare eiciența similară cu metodele endourologice clasice și siguranța sporită a tehnicii, vaporezecția transuretrală Thulium laser este recomandabilă utilizării pe larg</p></cfAbstr> <cfAbstr cfLangCode='EN' cfTrans='o'><p>Benign prostatic hyperplasia is the most common cause of lower urinary tract symptoms. Currently, surgical treatment remains the most efective treatment option for these patients. According to the studies, the use of Thulium laser transurethral surgery signiicantly reduce the risk of bleeding and basically excludes the possibility of TUR syndrome. Taking into account it's eiciency, similar to classical endourological methods and increased safety of the technique, Thulium laser transurethral vaporization is advisable for the extensive use.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-47618</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-16000</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-30120</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-67892</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-11096</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-47618</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-47618-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> <cfFamilyNames>Pleşacov</cfFamilyNames> <cfFirstNames>Alexei</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-16000</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-16000-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> <cfFamilyNames>Vladanov</cfFamilyNames> <cfFirstNames>Ivan</cfFirstNames> <cfFamilyNames>Владанов</cfFamilyNames> <cfFirstNames>И.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-30120</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-30120-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> <cfFamilyNames>Scutelnic</cfFamilyNames> <cfFirstNames>Ghenadie</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-67892</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-67892-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> <cfFamilyNames>Colța</cfFamilyNames> <cfFirstNames>Artur</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-11096</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11096-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-04-01T24:00:00</cfStartDate> <cfFamilyNames>Ghicavîi</cfFamilyNames> <cfFirstNames>Vitalie</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>